Dorian Therapeutics Company
%20.jpg)
FIGHTING AGING. We block senescence at the cellular level to improve medical conditions
Last Funding Type:
Seed
Headquarters:
United States
Investors Number:
1
Technology:
Geroscience
Employee Number:
1-10
Industry:
Others
Estimated Revenue:
Less than $1M
Number Of Exists:
Seed
Funding Status:
Seed
Investor Type:
Company